Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

@article{Tynjl2008AdalimumabIJ,
  title={Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.},
  author={Pirjo Tynj{\"a}l{\"a} and Kaisu Kotaniemi and Pernilla Lindahl and Katariina Latva and Kristiina Aalto and V. Honkanen and Pekka Lahdenne},
  journal={Rheumatology},
  year={2008},
  volume={47 3},
  pages={339-44}
}
OBJECTIVE To evaluate the efficacy of adalimumab in juvenile idiopathic arthritis (JIA)-associated uveitis. METHODS Retrospective observational study of 20 patients with JIA and chronic uveitis on adalimumab treatment. The ocular inflammation and improvement was assessed according to the Standardization of Uveitis Nomenclature criteria. RESULTS At the initiation of adalimumab, the mean age of patients was 13.4 yrs and the mean duration of uveitis 8.7 yrs. Seventeen (85%) patients had… CONTINUE READING